Products

GyriCalc
NeuroSpectrum Insights
Neurology AI
GyriCalc is a proprietary, patented software solution specifically designed to assist in the diagnosis of autism by identifying early structural markers of neurodevelopmental differences through the automated analysis of MRI images.

See all 1 product →

About NeuroSpectrum Insights

NeuroSpectrum Insights is a medical device company that leverages AI to enhance the diagnosis of neurological and neurodevelopmental disorders. Their flagship product, GyriCalc, is a patented software solution designed to assist physicians in diagnosing autism. It achieves this by identifying early structural markers of neurodevelopmental differences through the automated measurement and analysis of MRI images. The company’s technology has demonstrated high accuracy, with reports indicating up to 94% accuracy in identifying autism.

NeuroSpectrum Insights aims to address the inefficiencies in current diagnostic processes, such as long waitlists and subjective evaluations, by providing an objective and accessible diagnostic tool.5 months after submission. While their initial focus is on autism diagnosis in the United States and Canada, NeuroSpectrum Insights plans to expand its brain analysis software algorithms to support clinicians in diagnosing other neurological conditions, including dyslexia, ADHD, and schizophrenia. They project to generate over $40 million in annual revenue in 2029.

For physicians, NeuroSpectrum Insights offers a tool that can potentially shorten the time to diagnosis for neurodevelopmental conditions like autism, accelerating access to critical therapeutic interventions. The software analyzes structural MRIs, providing data-driven results that can aid in objective diagnosis, even in children as young as nine months old. This technology could be particularly valuable in addressing the shortage of diagnosticians and the subjective nature of traditional diagnostic processes, ultimately leading to earlier and more appropriate treatment for patients.

Focus Areas

diagnosing neurological disorders neurodevelopmental disorders autism diagnosis MRI analysis brain gyrification computer-aided diagnostics early detection

Business Intelligence

TechnologyGyriCalc software, AI-powered computerized analysis, structural MRI analysis, cerebral cortex analysis, surface characteristics analysis, Local Gyrification Index algorithm (C++), web application (Django/React) for DICOM upload, processing, and clinical reporting

What Physicians Need to Know

Specialization
NeuroSpectrum Insights specializes in diagnosing neurological and neurodevelopmental disorders, with a primary focus on autism diagnosis. They utilize computer-aided diagnostics and MRI analysis, particularly focusing on brain gyrification, for early detection.
Key Differentiators
Their flagship product, GyriCalc, is an FDA-cleared, proprietary, and patented software solution designed to assist in the diagnosis of autism by identifying early structural markers of neurodevelopmental differences through automated analysis of MRI images. This technology aims to provide objective, data-driven results to shorten the time to diagnosis, potentially as early as 9 months old, with reported accuracy rates of over 90%. This contrasts with traditional behavioral assessments that often lead to diagnoses much later, around 4-5 years of age.
Technology Stack
NeuroSpectrum Insights leverages advanced imaging post-processing software, GyriCalc, which performs automatic labeling, visualization, volumetric quantification, surface area, thickness, and gyrification analysis of brain structures from MRI images. The software uses customized, state-of-the-art open-source software and has been rebuilt in modern C++ with full parallelization, featuring a web application (Django/React) for DICOM upload, processing, and clinical reporting.
Brain Gyrification Analysis
The company's core technology analyzes brain gyrification, the intricate folding patterns of the cerebral cortex, which is a key indicator in neurodevelopment. Abnormalities in gyrification are associated with neurodevelopmental disorders. GyriCalc labels over 14 functional brain regions and measures cortical folding patterns to provide objective biomarkers.
Early Detection Focus
A significant emphasis is placed on early detection of autism and other neurodevelopmental disorders. Early intervention, especially before the age of three, has been shown to significantly improve outcomes for individuals with autism, including enhanced cognitive and social skills. NeuroSpectrum Insights aims to provide earlier answers and facilitate timely access to critical therapeutic interventions.
Physician Tip

NeuroSpectrum Insights offers physicians a tool for earlier and more objective diagnosis of autism and potentially other neurodevelopmental disorders, moving beyond subjective behavioral observations. GyriCalc's FDA clearance and high accuracy rates (over 90%) in identifying structural brain markers from MRIs can significantly shorten the diagnostic timeline, allowing for earlier intervention and potentially better patient outcomes. This technology can be particularly valuable in addressing the shortage of diagnosticians and the inefficiencies of traditional diagnostic processes. While currently focused on autism, the underlying technology may expand to other neurological conditions like dyslexia, ADHD, and schizophrenia. Physicians should note that while GyriCalc has received FDA marketing clearance, it has not yet received FDA clearance for diagnostic use.

GyriCalc is designed to integrate with existing MRI imaging workflows, accepting DICOM format as input. It provides segmented images and morphometric reports, which can be incorporated into clinical assessments. The software is compatible with 3D T1 MRI scans. The company's focus on a software-as-a-medical-device (SaMD) approach suggests potential for seamless integration into digital healthcare ecosystems.

Products by NeuroSpectrum Insights

1 product in the directory

GyriCalc
NeuroSpectrum Insights
Neurology AI
GyriCalc is a proprietary, patented software solution specifically designed to assist in the diagnosis of autism by identifying early structural markers of neurodevelopmental differences through the automated analysis of MRI images.

Videos

News, demos, and interviews about NeuroSpectrum Insights.

Loading videos...

Videos load interactively. If none appear, search YouTube for NeuroSpectrum Insights →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

NeuroSpectrum Insights leverages advanced AI and machine learning algorithms to analyze structural MRI data, focusing on subtle biomarkers like brain gyrification patterns. This computer-aided diagnostic approach enhances the early detection and differential diagnosis of various neurological and neurodevelopmental conditions, including autism spectrum disorder, by providing quantitative, objective insights that complement traditional clinical assessments.
Our flagship product, NeuroScan AIu2122, is a cloud-based platform designed for seamless integration with existing PACS and EMR systems. It processes raw MRI data to generate comprehensive reports on brain morphology, gyrification indices, and other relevant biomarkers, providing clinicians with actionable insights directly within their workflow.
NeuroSpectrum Insights is fully compliant with HIPAA regulations, ensuring the utmost privacy and security of patient health information through robust encryption, access controls, and regular security audits. We are actively pursuing FDA clearance for our diagnostic tools, with ongoing clinical validation studies to demonstrate efficacy and safety.
Our pricing model is typically subscription-based, offering tiered plans tailored to the volume and specific needs of healthcare institutions, with options for per-scan or annual licensing. Healthcare providers often see a significant ROI through improved diagnostic accuracy, reduced time to diagnosis, optimized patient pathways, and enhanced clinical confidence, leading to better patient outcomes and resource utilization.
NeuroSpectrum Insights offers comprehensive support, including dedicated onboarding specialists for initial setup and EMR/PACS integration, extensive training for clinical staff, and 24/7 technical support. Our goal is to ensure a smooth transition and continuous optimal performance, empowering your team to fully leverage our diagnostic capabilities.
Yes, we actively collaborate with leading academic research institutions and other healthcare technology innovators to advance our understanding of neurological disorders and refine our diagnostic algorithms. These partnerships are crucial for clinical validation, expanding our biomarker discovery, and ensuring our product roadmap remains at the forefront of neuroimaging and AI diagnostics.
NeuroSpectrum Insights is backed by strong venture capital funding and a clear long-term vision focused on becoming the global leader in AI-powered neurodevelopmental and neurological diagnostics. Our commitment to continuous R&D, strategic partnerships, and a robust financial foundation ensures sustained support for our clients and ongoing innovation in the field.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.